Upload Avatar (500 x 500)
Jun Zhang
Chinese, English
Fujian
Xiamen University
Medical
  • 1994-1997 Master's in Epidemiology: Shanghai Medical University
  • 1989-1994 Bachelor's in Preventive Medicine: Shanghai Medical University
  • Changjiang Scholar
  • National High-Level Talent Special Support Plan Leading Talent
  • National Innovation Award
  • National Technological Invention Second Prize
  • National Science and Technology Progress Second Prize
  • China Youth Scientist Award
  • Qiu Shi Outstanding Science and Technology Achievement Collective Award
  • 70th Anniversary of the Founding of New China Commemorative Medal
  • China May Fourth Youth Medal
  • 2011-present - Xiamen University School of Public Health - Professor
  • 2006-present - Xiamen University State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics - Deputy Director, Professor
  • 2002-2006 - Xiamen University School of Life Sciences - Associate Professor
  • 1997-2002 - Xiamen University School of Life Sciences - Assistant Professor
  • National Innovation Award: Detail
  • National Technological Invention Second Prize: Detail
  • National Science and Technology Progress Second Prize: Detail
  • China Youth Scientist Award: Detail
  • Qiu Shi Outstanding Science and Technology Achievement Collective Award: Detail
  • 70th Anniversary of the Founding of New China Commemorative Medal: Detail
  • China May Fourth Youth Medal: Detail
Vaccine Research
Diagnostic Research
  • Long-Term Efficacy of a Vaccine against Hepatitis E, Jun Zhang, Xue-Feng Zhang, Shou-Jie Huang, et al., 2015
  • Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial, Zhu FC, Zhang J, Zhang XF, et al., 2010
  • A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice, Zhang TY, Zhang J, et al., 2020
  • Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: An interim analysis of a randomized clinical trial, Qiao YL, Zhang J, Xia NS, et al., 2020
  • Sex differences in the incidence and clearance of anogenital human papillomavirus infection in Liuzhou, China: an observational cohort study, Wei F, Zhang J, Xia N, 2020
  • Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset, Lou B, Zhang J, Xia NS, Chen Y, 2020
  • Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019, Zhao J, Zhang J, Xia N, Zhang Z, 2020
  • Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China, Ji MF, Zhang J, Cao SM, 2019
  • Prevalence, Concordance, and Transmission of Human Papillomavirus Infection Among Heterosexual Couples in Liuzhou, China: An Observational Perspective Study, Su Y, Wei F, Zhang J, 2019
  • Influence of Mutations in Hepatitis B Virus Surface Protein on Viral Antigenicity and Phenotype in Occult HBV Strains from Blood Donors, Huang CH, Zhang J, Xia NS, 2012
  • Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity, Zhang J, Zhang XF, Zhou C, et al., 2014
  • Cytomegalovirus Shedding in Healthy Seropositive Female College Students: A 6-Month Longitudinal Study, Huang Y, Guo X, Zhang J, 2018
Vaccine Development Molecular Diagnostics Infectious Diseases Public Health Epidemiology Clinical Trials Immunology Biotechnology Preventive Medicine Healthcare Innovation

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.